Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine vs Compazine for Headache in ED
NCT02735343Phase 3Terminated
- Sponsor
- Mike O'Callaghan Federal Medical Center
- Start
- Aug 2016
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in Headache, migraine, sponsored by Mike O'Callaghan Federal Medical Center. Started Aug 2016; status: terminated.
02
Drugs
ketamine
03
Conditions
Headachemigraine
Beyond the preview
Go deeper on NCT02735343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735343.